Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Akebia Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- −10 vs. Q2 2021
- Shares held
- 98.5M
- −7.56M (−7.1%) vs. Q2 2021
- Total value
- $283.7M
- −$118.3M (−29.4%) vs. Q2 2021
- New holders
- 12
- 49 more added
- Sold out
- 22
- 36 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $123.2M |
| Q1 2026 | 171 | $141.4M |
| Q4 2025 | 166 | $190.4M |
| Q3 2025 | 177 | $337.7M |
| Q2 2025 | 158 | $394.1M |
| Q1 2025 | 143 | $182.7M |
| Q4 2024 | 121 | $128.9M |
| Q3 2024 | 114 | $78.4M |
| Q2 2024 | 103 | $57.4M |
| Q1 2024 | 114 | $104.3M |
| Q4 2023 | 87 | $72.7M |
| Q3 2023 | 76 | $58.0M |
| Q2 2023 | 79 | $46.0M |
| Q1 2023 | 65 | $29.1M |
| Q4 2022 | 75 | $30.2M |
| Q3 2022 | 90 | $16.5M |
| Q2 2022 | 97 | $20.2M |
| Q1 2022 | 124 | $58.3M |
| Q4 2021 | 133 | $218.7M |
| Q3 2021 | 127 | $283.7M |
| Q2 2021 | 139 | $402.4M |
| Q1 2021 | 145 | $340.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 514,258 | $1.48M | 0.00% | −2,593,278−83.5% | Reduced |
| UBS Group AG | 528,845 | $1.52M | 0.00% | +390,489+282.2% | Added |
| Principal Financial Group Inc | 539,832 | $1.55M | 0.00% | −8,036−1.5% | Reduced |
| Rice Hall James & Associates, LLC | 566,026 | $1.63M | 0.06% | +13,050+2.4% | Added |
| Nuveen Asset Management, LLC | 572,999 | $1.66M | 0.00% | −7,011−1.2% | Reduced |
| PDT Partners, LLC | 581,700 | $1.68M | 0.12% | −2,900−0.5% | Reduced |
| Bank of New York Mellon Corp | 591,829 | $1.70M | 0.00% | +29,674+5.3% | Added |
| PKO Investment Management Joint-Stock Co | 622,796 | $1.79M | 0.22% | −4,536−0.7% | Reduced |
| Rafferty Asset Management, LLC | 673,939 | $1.94M | 0.01% | +78,993+13.3% | Added |
| Susquehanna International Group, LLP | 788,213 | $2.27M | 0.00% | −156,615−16.6% | Reduced |
| Renaissance Technologies LLC | 949,927 | $2.74M | 0.00% | −877,803−48.0% | Reduced |
| Prudential Financial Inc | 1,083,905 | $3.12M | 0.00% | +1,062,864+5,051.4% | Added |
| Morgan Stanley | 1,473,505 | $4.24M | 0.00% | −1,186,868−44.6% | Reduced |
| Orchard Capital Managment, LLC | 1,593,531 | $4.59M | 1.38% | 00.0% | Unchanged |
| Northern Trust Corp | 1,772,171 | $5.10M | 0.00% | +81,363+4.8% | Added |
| Federated Hermes, Inc. | 2,029,103 | $5.84M | 0.01% | +145,327+7.7% | Added |
| Dimensional Fund Advisors LP | 2,095,763 | $6.04M | 0.00% | −1,309,358−38.5% | Reduced |
| Woodline Partners LP | 2,323,517 | $6.69M | 0.11% | +2,199,743+1,777.2% | Added |
| Jacobs Levy Equity Management, Inc | 2,662,045 | $7.67M | 0.05% | −245,289−8.4% | Reduced |
| Geode Capital Management, LLC | 3,229,943 | $9.30M | 0.00% | +307,291+10.5% | Added |
| JPMorgan Chase & Co | 4,565,735 | $13.2M | 0.00% | −382,042−7.7% | Reduced |
| Satter Management Co., L.P. | 4,652,561 | $13.4M | 9.17% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 4,978,195 | $14.3M | 0.85% | −191,868−3.7% | Reduced |
| Marshall Wace, LLP | 6,968,811 | $20.1M | 0.10% | +2,859,222+69.6% | Added |
| Vanguard Group Inc | 12,411,243 | $35.7M | 0.00% | +255,524+2.1% | Added |
| BlackRock Inc. | 14,052,487 | $40.5M | 0.00% | +877,806+6.7% | Added |
| State Street Corp | 15,856,428 | $45.7M | 0.00% | +1,849,791+13.2% | Added |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −10,736,859−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −267,603−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −264,954−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −62,446−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −51,044−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −46,270−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −41,781−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −41,564−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,589−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −19,195−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −18,732−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −18,451−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −17,189−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −10,636−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −6,300−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −947−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −843−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −309−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −383−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |
| First Horizon Corp | – | – | – | – | Not filed |